Form 10-12G/A SLR Secured Specialty
Table of Contents
As filed with the Securities and Exchange Commission on October 8, 2026
File No. 000-56862
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment No. 4
FORM 10
GENERAL FORM FOR REGISTRATION OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934
SLR SECURED SPECIALTY LENDING FUND
(Exact name of registrant as specified in charter)
| Delaware | 42-6842219 | |
| (State or other jurisdiction of incorporation or registration) |
(I.R.S. Employer Identification No.) | |
| 500 Park Avenue New York, NY |
10022 | |
| (Address of principal executive offices) | (Zip Code) | |
(212) 993-1670
(Registrant’s telephone number, including area code)
with copies to:
Thomas J. Friedmann
Dechert LLP
One International Place, 40th Floor
100 Oliver Street
Boston, MA 02110
(617) 728-7100
Securities to be registered pursuant to Section 12(b) of the Exchange Act:
| Title of each class to be so registered |
Name of exchange on which each class is to be registered | |
| None | N/A |
Securities to be registered pursuant to Section 12(g) of the Exchange Act:
Common Shares, par value $0.001 per share
(Title of class)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
| Non-accelerated filer | ☒ | Smaller reporting company | ☐ | |||
| Emerging growth company | ☒ | |||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Table of Contents
Table of Contents
This Amendment No. 4 to Form 10 (this “Amendment”) amends the Registration Statement on Form 10 of SLR Secured Specialty Lending Fund as first filed with the Securities and Exchange Commission (“SEC”) on July 14, 2026 and as amended by Amendment No. 1 to Form 10 filed with the SEC on August 11, 2026, and by Amendment No. 2 to Form 10 filed with the SEC on August 13, 2026 and by Amendment No. 3 to Form 10 filed with the SEC on October 11, 2026 (as so amended, the “Registration Statement”). This Amendment is being filed to include an unaudited schedule of the investments SLR Secured Specialty Lending Fund (the “Fund”) acquired as part of its Initial Portfolio Investments. In accordance with Rule 12b-15 under the Exchange Act, this Amendment No. 4 amends only Item 15 of Form 10. No other changes were made to the Registration Statement.
The Registration Statement became effective automatically sixty days after it was initially filed with the SEC, and the Fund is currently subject to the reporting and other requirements of the Exchange Act and the rules promulgated thereunder.
This Amendment No. 4 should be read in conjunction with the prior filings and any subsequent filings of the Fund with the SEC.
ITEM 15. FINANCIAL STATEMENTS AND EXHIBITS.
(a) List separately all financial statements filed.
The financial statements included in this Registration Statement are listed “Item 13. Financial Statements and Supplementary Data.”
| (b) | Exhibits |
Exhibit Index
| * | Previously filed |
| ** | Filed herewith |
1
Table of Contents
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized.
| SLR SECURED SPECIALTY LENDING FUND | ||
| By: | /s/ Michael Gross | |
| Name: | Michael Gross | |
| Title: | Trustee | |
Date: October 8, 2026
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Photodynamic Therapy Market to Reach USD 7.79 Billion by 2031 as Skin Cancer Treatment and Next-Generation Photosensitizers Support Growth
- Walmart Opens Next-Generation Fulfillment Center in Stockton, Expanding Faster Delivery Across the West Coast
- WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share